GSK, PSN introduce online training for pharmacists
Multinational pharmaceutical giant, GlaxoSmithKline, (GSK) has partnered the Pharmaceutical Society of Nigeria (PSN) to introduce an innovative online training program for pharmacists in the country.
The programme, tagged Scientific Course for Pharmacist Education (SCOPE), is aimed at enhancing the knowledge of Nigerian Pharmacists. According to the partners, SCOPE, a non-promotional and free online training program for Pharmacists, consists of nine (9) disease area modules that is accredited by the United States-based Accreditation Council for Pharmacy Education (ACPE).
Speaking at the signing of the memorandum of understanding (MOU) between the partners, the PSN President, Pharm. Olumide Akintayo disclosed that the successful completion of SCOPE is now one of the requirements to receive ten (10) credit points towards the required thirty (30) credit points under the Mandatory Continuous Professional Development (MCPD) programme of the Pharmacist’ Council of Nigeria (PCN).
Pharm. Olumide Akintayo noted that the partnership with GSK would further strengthen PSN’s doggedness to promote and maintain a high standard of pharmaceutical education in Nigeria, stressing that, SCOPE “facilitates a future grounded on professionalism through new frontiers in quality education updates.’’
Also in a short remark, Managing Director, GSK, Mr. Lekan Asuni stated that the MOU signing marked a milestone for not only the Partners, PSN and GSK, but also for the pharmaceutical industry as a whole.
“We consider this education partnership a great opportunity for us at GSK to fulfil our mission of improving the quality of human life. Through this innovative programme, SCOPE, we aim to enhance the knowledge of Nigerian pharmacists, and in turn, positively impact the lives of patients in Nigeria.
“The online platform was chosen to implement the modules because it’s more cost effective than face-to-face trainings with a wider reach as pharmacists in hard-to-reach area can benefit. Access to quality education will indeed build credibility in the Pharmaceutical industry,” he said.
GSK’s Commercial Development Manager, Africa & Developing countries in Asia (ADC) Mr. Jide Adeosun, on his part, commended PSN for pioneering the partnership with the company, saying GSK would similar programmes across Africa.
A 2013 survey conducted in Nigeria revealed that 50 per cent of Pharmacists seek training as a value added service from GSK. This need led to the development and launch of SCOPE, which is designed to enhance the knowledge base of pharmacists and improve pharmaceutical care outcomes for patients at the pharmacy.
Among key opinion leaders in attendance were heads of departments of pharmacy in Teaching Hospitals and Hospitals across the Southwest region of Nigeria; Mrs Juliet Ehimuan, Google Nigeria Country Manager, Mrs. Awofuwa, Director of Pharmacy, General Hospital, Ajeromi; Pharm. Bukky George, C.E.O, Health Plus, Pharm Dorcas Omeire, University Of Lagos Medical Centre, Mrs. Nmadu, Director of Pharmacy, Central Bank Of Nigeria Staff Clinic, Pharm Bolanle Adekoya, Deputy Director of Pharmacy, Lagos University Teaching Hospital Idi-Araba, Pharm Salami, Director of Pharmacy, Health Service Commission and host of other dignitaries within the industry.
About author
You might also like
Kenya pilots breakthrough lymphatic filariasis treatment
A lymphatic filariasis patient NAIROBI, Kenya: IDA treatment, a new triple drug therapy with the potential to reduce the time to treat and break transmission of lymphatic filariasis (LF) from
PSN worries over rate of members leaving Nigeria
The Pharmaceutical Society of Nigeria, (PSN), has expressed worry over the rate its members are leaving the country for greener pastures. Chairman of the association, Osun State chapter, Prof Moses
Experts advocate comprehensive NHIS cover for diabetes
as Sanofi Summit ends Experts at the one-day Diabetes Summit organized by Sanofi Aventis, a global biopharmaceutical healthcare company focused on human health on Wednesday October 17, have advocated a
0 Comments
No Comments Yet!
You can be first to comment this post!